个人情况介绍、概览

祁兴顺，男，博士，博士后。北部战区总医院消化内科主任，副主任医师，沈阳药科大学兼职硕士生导师。中华医学会消化病学分会第十一届委员会青年委员、肝胆疾病学组委员、微创介入协作组委员、中华医学会肝病学分会肝病相关消化病协作组委员、辽宁省医学会消化病学分会第十一届委员会常委。现任BMC Gastroenterology杂志Senior Editorial Board Member、Therapeutic Advances in Gastroenterology杂志Editorial Board Member、Canadian Journal of Gastroenterology and Hepatology杂志Academic Editor、Journal of Clinical and Translational Hepatology杂志Academic Editor、Advances in Therapy杂志Editorial Board Member、Journal of Translational Internal Medicine杂志Editorial Board Member、Frontiers in Medicine杂志Associate Editor、Medicine杂志Academic Editor。目前主要在《New England Journal of Medicine》、《Gastroenterology》及《Hepatology》等期刊上发表的病例及评论文章；在《Nature Reviews Gastroenterology & Hepatology》及《BMC Medicine》等权威期刊上发表的长篇综述文章；在《Journal of Hepatology》、《Alimentary Pharmacology & Therapeutics》及《Liver International》等期刊上发表的原创论著性文章。目前以第一/通讯作者在SCI杂志发表文章300余篇，累计IF(影响因子)＞1000。据Scopus统计，H-index为53，总共9874次引用。

人才称号、社会兼职等

1.中国科学技术协会第十次全国代表大会代表；
2.中国抗癌协会中西医结合癌前病变专业委员会副主任委员；
3.中华医学会消化病学分会第十一届委员会青年委员
4.中华医学会消化病学分会肝胆疾病学组委员；
5.中华医学会消化病学分会微创介入协作组委员；
6.中华医学会肝病学分会肝病相关消化病协作组委员；
7.辽宁省医学会消化病学分会第十一届委员会常务委员。

主要研究方向

主要从事消化系疾病的临床诊疗工作，尤其擅长肝硬化、门静脉高压、门静脉血栓、布加综合征、肝细胞癌的诊治。

纵向项目

无

论文

1.Machine learning based CAGIB score predicts in-hospital mortality of cirrhotic patients with acute gastrointestinal bleeding.npj Digital Medicine.2025.共同通讯作者（1/4）.(IF=15.1).中科院1区
2.Impact of non-selective beta blockers on further decompensation and death in decompensated cirrhosis: Benefit and risk stratification by MELD score.Alimentary Pharmacology & Therapeutics.2024.通讯作者.(IF=6.7).中科院1区
3.Editorial: how early should ‘early TIPSS’ be in cirrhosis with acute variceal bleeding?.Alimentary Pharmacology & Therapeutics.2023.通讯作者.(IF=9.542).中科院1区
4.Efficacy and safety of thrombolytic therapy for portal venous system thrombosis: A systematic review and meta-analysis.Journal of Internal medicine.2023.通讯作者.(IF=13.068).中科院1区
5.U-shaped relationship between subcutaneous adipose tissue index and mortality in liver cirrhosis.Journal of Cachexia, Sarcopenia and Muscle.2023.通讯作者.(IF=12.063).中科院1区
6.Incidence, risk factors, and prognosis of abnormal liver biochemical tests in COVID-19 patients: a systematic review and meta-analysis..Hepatology Int.2020.通讯作者.(IF=5.49).中科院2区
7.Nonselective beta-blockers and development of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis..Hepatol Int..2019.通讯作者.(IF=5.49).中科院2区
8.Association of non-selective beta blockers with the development of renal dysfunction in liver cirrhosis: a systematic review and meta-analysis..Ann Med.2024.共同通讯作者（1/2）.(IF=4.4).中科院2区
9.Endoscopic removal of esophageal foreign body and endoscopic closure of its associated perforation with early mediastinitis..Rev Esp Enferm Dig.2024.通讯作者.(IF=3).中科院2区
10.Efficacy and safety of thrombolytic therapy for portal venous system thrombosis: A systematic review and meta-analysis.Journal of Internal Medicine.2023.共同通讯作者（1/2）.(IF=9.2).中科院1区

学术成果

1.复杂门静脉高压症TIPS治疗策略的建立及应用.中央军委科学技术委员会.2017
2.终末期肝病诊疗及预后评价新体系的研究.辽宁省医学会.2021
3.Transient portal vein thrombosis in liver cirrhosis.辽宁省科协和辽宁省人社厅.2019
4.建立并验证辽宁评分预测肝硬化食管静脉曲张价值.辽宁省科协和辽宁省人社厅.2022